SAPA 14th Annual Conference Program


Opportunities & Challenge:

Pharmaceutical and Biotechnology Innovation and Globalization

 

August 18-20, 2006

 

Yusheng Wu, Ph.D., SAPA President & Conference Chair

Charles Wang, Ph.D., SAPA President-Elect & Conference Co-Chair

Xiaohui Mei, Ph.D., Conference General Secretary

 

 

Friday, August 18

1:30 – 5:30 pm

                      Location TBD

 

Pre-conference Workshop:

“IND Filling: Basic requirements and strategy”

 

 

Workshop Chairs:  George Xiao & Xiaohui Mei

 

Lecture/Tutorial and Interactive Session

 

 

In this workshop, there will be professionals in the field to provide a tutorial and lectures on how to successfully open an IND and avoid the most common mistakes.  Real case studies will be examined and discussed.

 

Non-clinically Successful Filing of INDs

Dr. Luqi Pei

Sr. Pharmacologist/Toxicologist

CDER, FDA

 

“ADME Requirements and strategies for IND filing”

Dr. Handan He

Associate Director, Head of ADME

Novartis Pharmaceuticals Inc.

 

“CMC Requirements and strategies for IND filing”

Dr. Sherry Ku

Sr. Director of Pharmaceutical Science

Wyeth

 

Clinical considerations of IND filing”

Dr. Simon Li

Vise-President of Medical Research

Neuromed Pharmaceuticals Inc.

 

 

 

 

Speaker and Sponsor Reception

Friday, August 18, 6:30 – 9:30 pm

Location TBD

 


Saturday, August 19
Busch Campus Center, Rutgers University, Piscataway, NJ 08854

Registration and Breakfast - 7:30am to 8:30am

 

Plenary Session

8:30 am to 12:30 pm

 

 Chair: Dr. Yusheng Wu

 

 

Keynote Speakers:

 

Dr. Lee Babiss, VP, Hoffmann-La Roche (confirmed)

 

 “Metabolic Syndrome and Endoconnahwird System”

Dr. Paul Chew, VP, Sanofi-Aventis (confirmed)

 

Dr. Mauricio Futran, VP, BMS (invited)

 

Dr. Herman Van Cauteren, Sr. VP J&JPRD (confirmed)

 

"Innovative Drug Discovery in China: Mission Possible?"

Dr. En Li, Vice President and Global

Head of Models of

Disease Center, Novartis Institutes for BioMedical Research (Invited)

 

 

Opening Remark:

 

 


Afternoon Session - 1:30 pm to 5:30 pm

 

Parallel Session 1

 

China Pharmaceutical & Biotech Forum

Chair: Drs Mingde Xia & Huayi Tong

 

 

“Talk Title-TBD”

Mr. Zegong Zhang

Vice Director

Beijing Pharma & Biotech Center (BPBC)

 

 

“Talk Title-TBD”

Dr. Li Chen

CSO

Roche R&D China

 

 

“The world is flat-R&D outsourcing in China”

Dr. Ge Li

CEO

Wuxi Pharmatech

 

 

“Pharmaceutical brand communication”

Mr. Tony Y. Zhang

Managing Partner

BizPro International

 

 

“Talk Title-TBD”

Mr. Kewen Jin

CEO

Shanghai BioExplorer

 

 

“Talk Title-TBD”

Ms. Maggie Wang

General Manager

Zhejinag Lianhe Chemical Technology

 

“Talk Title-TBD”

Mr. Hai Wang

VP

Zhejinag Huahai


Parallel Session 2

 

Career Development

 

Chairs: Drs. Gen Li & Bill Wei

 

“Talk Title-TBD”

Dr. Ge Li

CEO

Wuxi Pharmatech

 

 

“Talk Title-TBD”

Dr. Xu Bibo

Analytical lab (Invited)

 

 

“Talk Title-TBD”

Dr. Xiongwei Shi

CEO

Shanghai United Pharmatech

 

 

“Talk Title-TBD”

Jin Wang

Manhattan Capital

 

 

“Talk Title-TBD”

Janet Leduox

Director, Human Resource

J&JPRD

 

 


Parallel Session 3

Natural Products and Function Foods

Chairs: Drs. Qunyi Zheng & Weizhu Yu

 

 

“Health Benefits of Antioxidants and Balanced Foods for Chronic Disease Prevention”

Rui Hai Liu, M.D., Ph.D.
Associate Professor

Cornell University

 

                       

“Nanotechnology in Functional Foods Research”

Qingrong Huang, Ph.D

Assistant Professor

Rutgers, The State University of New Jersey

 

 

“Talk Title-TBD”

Qunyi Zheng, Ph.D

President

Kent Financial Services

 

 

 

Banquet

7:00 PM-9:30 PM

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Sunday, August 20
Busch Campus Center, Rutgers University, Piscataway, NJ 08854

 

After-Conference Session

 

Chairs: Drs. Min Li & Jianji Wang

 

China Pharmaceutical & Biotech Forum

“The successful story of the returnees”

(English/Chinese Speaking)

 

1:30 am to 5:30 pm

 

 

“Talk Title-TBD”

Dr. Xiongwei Shi

CEO

Shanghai United Pharmatech

 

  

 “Talk Title-TBD”

Mr. Kechun Li

General Manager

Chiral Quest China

 

 

“Talk Title-TBD”

Jin Wang

Manhattan Capital

 

 

“Talk Title-TBD”

Dr. Guohua Zhang (invited)

Senior VP

Andrx Pharmaceuticals

 

 

“Talk Title-TBD”

Mr. Ye Liu

VP

Beijing Bioengineering & Pharmaceutical Industrial park

 

 

“Talk Title-TBD”

Dr. Jason Gang Jin

President

MaxyBio Corporation

 

 

 “Talk Title-TBD”

Dr. Don Qiu

CEO

Beijing Joinn Pharmaceutical Center

 

 

 “Talk Title-TBD”

Mr. Pau Guo (CEO)/Mr. Bin Yu

VP

Astatech

 

 

“Talk Title-TBD”

Dr. Julie Jia

Drug Discovery Specialist

Millipore

 

 

The pharmaceutical industry and pharmaceutical market status of China

Ms. Huifang Wu

Vice General Manager

Beijing Orientbit Technology

 

 

“Talk Title-TBD”

Dr. Jin Ren

Director, Drug Safety Evaluation Center

Shanghai Institute of Materia Medica, CAS